In RA, bone loss is exacerbated by the excessive production of inflammatory cytokines, especially tumor necrosis factor α (TNF‐α), in the local environment of the inflamed joint, which results in increased osteoclast differentiation and subchondral bone degradation as well as systemic bone loss 1, 2. Here, TNF is linked to rheumatoid arthritis.